Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-05-17
1986-04-01
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546286, 546321, 546257, 546258, A61K 31455, C07D21190, C07D40104
Patent
active
045798591
ABSTRACT:
The invention relates to novel dihydropyridine derivatives of vasodilating activity of the formula: ##STR1## in which R.sup.1 is aryl selected from the group consisting of phenyl, tolyl, xylyl, cumenyl and mesityl which may have one or more substituents selected from the group consisting of halogen, nitro, hydroxy, carboxy and lower alkoxy, or a heterocyclic group containing at least one hetero atom selected from the group consisting of oxygen, nitrogen and sulfur,
REFERENCES:
patent: 3427295 (1969-02-01), Reed
patent: 4370334 (1983-01-01), Sato
patent: 4423052 (1983-12-01), Araki et al.
patent: 4472411 (1984-09-01), Hatayama et al.
Bossert, et al., "4 Aryldihydropyridines", Angew. Chem. Int. Ed. Engl. 20, 762-769 (1981).
Schramm, et al., "Novel Dihydropyridines with Positive Inotropic Action", Nature vol. 303 (9 Jun. 1983) pp. 535-537.
Morino Daizo
Takimoto Koichi
Ueda Ikuo
Bjorkman Dale A.
Fujisawa Pharmaceutical Co. Ltd.
Jiles Henry R.
LandOfFree
Vasodilating trinitratoalkyl esters of 2-cyano-1,4-dihydropyridi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vasodilating trinitratoalkyl esters of 2-cyano-1,4-dihydropyridi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasodilating trinitratoalkyl esters of 2-cyano-1,4-dihydropyridi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1084684